Back to AMLN Stock Lookup

Amylin Pharmaceuticals, Inc. (AMLN) – Major News

Jun 30, 2012 09:57 AM Bristol-Myers Squibb (BMY) Acquires Amylin (AMLN) for $31/Share
Jun 5, 2012 06:57 AM Amylin (AMLN) Bidding Intensifies; Sale Expected in July
May 15, 2012 08:35 AM Amylin (AMLN) Attracting a Host of Other Suitors, Shares Rise
Apr 26, 2012 07:06 AM Amylin Pharmaceuticals (AMLN) Posts Narrower than Expected Q1 Loss of 23c/Share
Mar 28, 2012 10:00 AM UPDATE: Amylin (AMLN) Rejected $22/Share Bid from Bristol-Myers (BMY)
Feb 6, 2012 04:43 PM Amylin Pharma (AMLN) Reports Q4 GAAP Loss of $3.15/Share
Oct 19, 2011 04:06 PM Amylin Pharmaceuticals, Inc. (AMLN) Posts Q3 Loss of $0.07, Sales Fall Short
Jul 26, 2011 07:33 AM Amylin Pharma (AMLN) Posts Wider than Expected Q2 Loss; Revs Beat
Apr 18, 2011 07:31 AM Amylin Pharmaceuticals (AMLN) Reports Q1 Loss of 24c, Misses by 1c
Apr 15, 2011 07:10 AM Eli Lilly (LLY) and Amylin's (AMLN) Announced BYDUREON Recommended for Approval in Europe
Jan 26, 2011 04:13 PM Amylin Pharma (AMLN) Posts Q4 adj.-Loss of $0.08
Nov 4, 2010 04:13 PM Amylin Pharma (AMLN) Posts Q3 GAAP Loss of $0.35; Revs Light
Oct 19, 2010 07:54 PM Amylin (AMLN), Alkermes (ALKS) and Eli Lilly (LLY) Hit With Request for More Tests from FDA on BYDUREON; Shares Set to Plunge
Jul 21, 2010 04:06 PM Amylin Pharm (AMLN) Tops Q2 EPS by 1c
Apr 19, 2010 07:08 AM Amylin Pharma (AMLN) Posts Q1 Loss of $0.27, Beats Views
Mar 15, 2010 06:47 AM Amylin (AMLN), Eli Lilly (LLY) and Alkermes (ALKS) Receive Complete Response Letter From FDA, But No New Trials Requested
Jan 27, 2010 04:06 PM Amylin (AMLN) Misses Street's Q4 Views
Nov 2, 2009 07:25 AM Amylin (AMLN) and Takeda Enter Development Agreement for Obesity Treatments
Oct 20, 2009 04:11 PM Amylin Pharma (AMLN) Reports Q3 Loss of $0.19, Beats by 10c
Jul 21, 2009 04:07 PM Amylin (AMLN) Reports Q2 Adj-Loss of $0.36, Misses by 1c
Jun 8, 2009 06:59 AM Amylin (AMLN) and Eli Lilly (LLY) Study Shows Pancreatitis Risk Is Not Increased with BYETTA
Apr 16, 2009 04:08 PM Amylin (AMLN) Reports Q1 Loss of $0.34, Misses by 1c
Jan 27, 2009 04:12 PM Amylin (AMLN) Reports Mixed Q4 Earnings
Oct 21, 2008 04:18 PM Amylin (AMLN) Reports Q3 Adj-Loss of $0.46, Misses by 4c
Aug 26, 2008 06:01 PM Amylin (AMLN) Issues Detailed Statement Regarding FDA Alert on BYETTA - Shares Down Almost 9% in After-Hours
Aug 18, 2008 12:36 PM FDA Issues Warning on Amylin's (AMLN) Byetta: Drug Linked to 6 Pancreatitis Cases -Bloomberg
Jan 28, 2008 04:11 PM Amylin Pharmaceuticals (AMLN) Misses Q4 EPS by 13c

Back to AMLN Stock Lookup